The Payer License Agreement, or “Netflix model,” for hepatitis C virus therapies enables universal treatment access, lowers costs and incentivizes innovation and competition

Liver International · Published 2022-07-01 · Available online 26 Mar 2022 · Journal article · DOI 10.1111/liv.15245 · Cited by 15 (Crossref)

Authors (4)

David W. Matthews, Samantha Coleman, Homie Razavi, Jean‐Manuel Izaret

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Volume
42
Issue
7
Pages
1503-1516
Year
2022

Citation

Matthews, D., Coleman, S., Razavi, H., et al. (2022). The Payer License Agreement, or “Netflix model,” for hepatitis C virus therapies enables universal treatment access, lowers costs and incentivizes innovation and competition. Liver International. https://doi.org/10.1111/liv.15245

Related articles

Metrics

Citations (Crossref)
15